Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $290 at Cantor Fitzgerald

October 8, 2026 7:10 AM
Cantor Fitzgerald analyst Carter Gould raised the price target on Abbvie (NYSE: ABBV) to $290.00 (from $285.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change